Published in Case Rep Neurol on June 01, 2010
Isolated superficial sylvian vein thrombosis with long cord sign: case report and review of the literature. Neurol Med Chir (Tokyo) (2013) 0.84
Radiological findings in cerebral venous thrombosis presenting as subarachnoid hemorrhage: a series of 22 cases. Neuroradiology (2015) 0.79
Isolated central sulcus hemorrhage: a rare presentation most frequently associated with cerebral amyloid angiopathy. Case Rep Radiol (2012) 0.75
Transient ischaemic attack: an exceptional presenting syndrome of a superior sagittal sinus thrombosis. BMJ Case Rep (2013) 0.75
The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain (2007) 4.80
Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology (2010) 2.22
MR imaging features of isolated cortical vein thrombosis: diagnosis and follow-up. AJNR Am J Neuroradiol (2008) 2.19
The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology (1993) 2.12
A restricted subarachnoid hemorrhage in the cortical sulcus in cerebral amyloid angiopathy: could it be a warning sign? Surg Neurol (2007) 1.42
Spontaneous isolated convexity subarachnoid hemorrhage: presentation, radiological findings, differential diagnosis, and clinical course. J Neurosurg (2008) 1.22
Isolated cortical venous thrombosis presenting as subarachnoid hemorrhage: a report of three cases. AJNR Am J Neuroradiol (2004) 1.20
Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage. Stroke (2009) 1.05
Cortical vein thrombosis: the diagnostic value of different imaging modalities. Neuroradiology (2010) 0.99
Clinical and neuroradiological spectrum of isolated cortical vein thrombosis. J Neurol (2005) 0.99
[Focal subarachnoid hemorrhage and cerebral amyloid angiopathy: a non-fortuitous association]. Rev Neurol (Paris) (2009) 0.85
Isolated cortical vein thrombosis in a patient with arteriovenous malformation. J Clin Neurosci (2009) 0.83
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Stroke. Lancet (2008) 9.51
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke (2008) 2.58
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol (2007) 2.46
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
Pixel-by-pixel spatiotemporal progression of focal ischemia derived using quantitative perfusion and diffusion imaging. J Cereb Blood Flow Metab (2003) 2.34
Notes from the field: Heartland virus disease - United States, 2012-2013. MMWR Morb Mortal Wkly Rep (2014) 2.33
Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke (2007) 2.25
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet (2011) 2.16
Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann Neurol (2004) 2.14
HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke (2005) 2.04
Functional, perfusion and diffusion MRI of acute focal ischemic brain injury. J Cereb Blood Flow Metab (2005) 2.01
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials. Stroke (2007) 1.62
Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke (2009) 1.61
Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (2007) 1.57
Differential recovery of behavioral status and brain function assessed with functional magnetic resonance imaging after mild traumatic brain injury in the rat. Crit Care Med (2007) 1.56
Dynamic tracking of acute ischemic tissue fates using improved unsupervised ISODATA analysis of high-resolution quantitative perfusion and diffusion data. J Cereb Blood Flow Metab (2004) 1.52
Acute postischemic renormalization of the apparent diffusion coefficient of water is not associated with reversal of astrocytic swelling and neuronal shrinkage in rats. AJNR Am J Neuroradiol (2002) 1.51
Effects of reperfusion on ADC and CBF pixel-by-pixel dynamics in stroke: characterizing tissue fates using quantitative diffusion and perfusion imaging. J Cereb Blood Flow Metab (2004) 1.49
Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke (2009) 1.48
Reprint: Good laboratory practice: preventing introduction of bias at the bench. J Cereb Blood Flow Metab (2008) 1.47
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices. Cerebrovasc Dis (2008) 1.37
The Virtual International Stroke Trials Archive. Stroke (2007) 1.34
A concerted appeal for international cooperation in preclinical stroke research. Stroke (2013) 1.32
Statistical prediction of tissue fate in acute ischemic brain injury. J Cereb Blood Flow Metab (2005) 1.30
Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol (2008) 1.30
Separating changes in the intra- and extracellular water apparent diffusion coefficient following focal cerebral ischemia in the rat brain. Magn Reson Med (2002) 1.26
International, multicenter randomized preclinical trials in translational stroke research: it's time to act. J Cereb Blood Flow Metab (2012) 1.24
Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model. J Cereb Blood Flow Metab (2008) 1.24
Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial. Stroke (2011) 1.22
The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods (2003) 1.19
AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke (2010) 1.19
Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy. Cerebrovasc Dis (2005) 1.16
Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke (2005) 1.11
Laser Doppler flowmetry predicts occlusion but not tPA-mediated reperfusion success after rat embolic stroke. Exp Neurol (2008) 1.09
Stroke: working toward a prioritized world agenda. Stroke (2010) 1.05
Microsphere-induced embolic stroke: an MRI study. Magn Reson Med (2004) 1.03
Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses. Int J Stroke (2012) 1.02
Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging. Stroke (2007) 1.02
Animal models of focal brain ischemia. Exp Transl Stroke Med (2009) 1.01
Stroke: working toward a prioritized world agenda. Cerebrovasc Dis (2010) 1.01
Normobaric hyperoxia - a promising approach to expand the time window for acute stroke treatment. Cerebrovasc Dis (2005) 1.00
The proteasome inhibitor VELCADE reduces infarction in rat models of focal cerebral ischemia. Neurosci Lett (2006) 1.00
Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good? Stroke (2010) 0.99
Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor. Stroke (2011) 0.98
Stimulating circle of Willis nerve fibers preserves the diffusion-perfusion mismatch in experimental stroke. Stroke (2007) 0.97
Long-term changes of functional MRI-based brain function, behavioral status, and histopathology after transient focal cerebral ischemia in rats. Stroke (2006) 0.96
Perfusion and diffusion imaging in acute focal cerebral ischemia: temporal vs. spatial resolution. Brain Res (2005) 0.95
Cardiac workup of ischemic stroke: can we improve our diagnostic yield? Stroke (2009) 0.94
Improving the accuracy of perfusion imaging in acute ischemic stroke. Ann Neurol (2011) 0.94
Comparison of ischemic lesion evolution in embolic versus mechanical middle cerebral artery occlusion in Sprague Dawley rats using diffusion and perfusion imaging. Stroke (2006) 0.93
Reprint: Good laboratory practice: preventing introduction of bias at the bench. Int J Stroke (2009) 0.93
Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model. J Cereb Blood Flow Metab (2005) 0.92
Visualization of clot lysis in a rat embolic stroke model: application to comparative lytic efficacy. Stroke (2011) 0.91
Differential recovery of multimodal MRI and behavior after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab (2006) 0.91
Comparison between coated vs. uncoated suture middle cerebral artery occlusion in the rat as assessed by perfusion/diffusion weighted imaging. Neurosci Lett (2006) 0.91
Spectacular shrinking deficit: insights from multimodal magnetic resonance imaging after embolic middle cerebral artery occlusion in Sprague-Dawley rats. J Cereb Blood Flow Metab (2007) 0.88
MRI of stroke using hyperpolarized 129Xe. NMR Biomed (2010) 0.88
Current practice versus willingness to enroll in clinical trials: paradox among vascular neurologists about treatment for acute ischemic stroke. Stroke (2010) 0.88
Characterization of gadolinium-based dynamic susceptibility contrast perfusion measurements in permanent and transient MCAO models with volumetric based validation by CASL. J Cereb Blood Flow Metab (2009) 0.86
Visualization of cortical spreading depression using manganese-enhanced magnetic resonance imaging. Magn Reson Med (2005) 0.85
Middle cerebral artery occlusion during MR-imaging: investigation of the hyperacute phase of stroke using a new in-bore occlusion model in rats. Brain Res Brain Res Protoc (2004) 0.85
Ischemic lesion volume determination on diffusion weighted images vs. apparent diffusion coefficient maps. Brain Res (2009) 0.84
Stroke: working toward a prioritized world agenda. Int J Stroke (2010) 0.84
Acute ischemic stroke therapy. Expert Rev Cardiovasc Ther (2010) 0.81
Posterior versus anterior circulation infarction: how different are the neurological deficits? Stroke (2012) 0.81
Use of telemedicine to increase thrombolysis and advance care in acute ischemic stroke. Cerebrovasc Dis (2009) 0.81
Investigation of techniques to quantify in vivo lesion volume based on comparison of water apparent diffusion coefficient (ADC) maps with histology in focal cerebral ischemia of rats. Magn Reson Imaging (2004) 0.80
Multi-modal approach for investigating brain and behavior changes in an animal model of traumatic brain injury. J Neurotrauma (2013) 0.80
REPRINT: International, multicenter randomized preclinical trials in translational stroke research: it is time to act. Stroke (2012) 0.80
Prophylactic neuroprotection. Curr Drug Targets (2007) 0.79
Partial-volume effect on ischemic tissue-fate delineation using quantitative perfusion and diffusion imaging on a rat stroke model. Magn Reson Med (2004) 0.78
Applications of diffusion/perfusion magnetic resonance imaging in experimental and clinical aspects of stroke. Curr Atheroscler Rep (2004) 0.78
Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke. Expert Rev Cardiovasc Ther (2006) 0.78
Considering the role of heparin and low-molecular-weight heparins in acute ischemic stroke. Stroke (2002) 0.78
Why the United States needs a network for stroke clinical trials. Stroke (2013) 0.77
Antihypertensive medications for risk reduction of first and recurrent ischemic stroke. Expert Rev Cardiovasc Ther (2004) 0.76
Thrombolytic therapy for acute ischemic stroke: 3 h and beyond. Expert Rev Neurother (2005) 0.76
Is penumbral imaging useful for extending the treatment window for intravenous tissue plasminogen activator? Ann Neurol (2006) 0.76
Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke. Stroke (2005) 0.76
NXY-059 for the treatment of stroke. N Engl J Med (2007) 0.76
The perils of combination antithrombotic therapy and potential resolutions. Circulation (2011) 0.76
Topical reviews. Stroke (2007) 0.75
Issues pertaining to the critiques of the SAINT-I Trial. Stroke (2007) 0.75
Headache and stroke: two common disorders or commonality of cause? Arch Intern Med (2003) 0.75
Reversal of diffusion abnormalities after ischemic stroke: adding difficulty and complexity to the conundrum of acute stroke imaging. Ann Neurol (2002) 0.75
Getting the word out on stroke guidelines. Circulation (2010) 0.75
The perils of combination antithrombotic therapy and potential resolutions. Stroke (2011) 0.75
Endovascular acute ischemic stroke therapy: applying basic science to clinical decisions. Neurology (2012) 0.75
Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use. Expert Rev Cardiovasc Ther (2003) 0.75
Emerging therapies for cerebrovascular disorders. Stroke (2004) 0.75
Specificities of Ischemic Stroke Risk Factors in Arab-Speaking Countries. Cerebrovasc Dis (2017) 0.75